医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

The First Smart Dispensing Robot EVV220 in Asia at Vejthani Hospital

2012年10月17日 PM05:55
このエントリーをはてなブックマークに追加


 

BANGKOK

Vejthani Hospital Bangkok offers cutting-edge technologies, with the ability to operate maximum safety and accuracy. We are thrilled to be the first hospital in Asia to have the new modern advanced technology, The Smart Dispensing Robot EVV220.

Vejthani Hospital Smart Dispensing Robot EVV220 is designed to reduce or eliminate the risk of cross contamination, simplifies a filling process, easy to use, incorporate and keep.

Advantages of Smart Dispensing Robot EVV220

  • The doctor’s order transmits directly to the Smart Robot.
  • Robotic Direct Fill
    - Vials are filled directly from the drug cassette, eliminating the risk of contamination and calibration errors.
  • Complete and Accurate Dispensing Robot
    - Doctor’s order transmits directly to the Smart Robot and verifies the barcode with the barcode scanner to locate corresponding vials.
  • The barcode scanner assures the right medication is refilled into its proper cassette.

Vejthani Hospital Bangkok became the first hospital in Asia to offer Smart Dispensing Robot EVV220, thus can improve the quality services offered in both inpatients and outpatients as well. Indeed modern advanced technology is going to have an even tremendous part in terms of quality healthcare services both local and international countries. If you want more information don’t hesitate to contact us.

Please Visit: Smart Dispensing Robot EVV220

CONTACT

Vejthani
Hospital

Harriet Marie, (+66)85-223-8888
Nurse
Information Online
webmaster@vejthani.com

同じカテゴリーの記事 

  • WHOOP宣布全球业务显著扩张,并任命新的高级领导层
  • SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
  • CORRECTING and REPLACING ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
  • Todd Clegg 担任 Carestream 首席执行官
  • Poxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release